Galectin Therapeutics Inc. ( NASDAQ:GALT – Get Free Report )’s share price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $3.22 and traded as low as $2.91. Galectin Therapeutics shares last traded at $2.97, with a volume of 396,557 shares traded.
Analysts Set New Price Targets
Several analysts recently issued reports on GALT shares. Zacks Research upgraded shares of Galectin Therapeutics from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Weiss Ratings restated a “sell (d-)” rating on shares of Galectin Therapeutics in a research report on Monday, September 14th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $11.00.
Get Galectin Therapeutics alerts:
Galectin Therapeutics Trading Up 5.4%
The firm has a market capitalization of $206.80 million, a P/E ratio of -7.30 and a beta of 0.53. The firm has a 50-day moving average of $3.74 and a two-hundred day moving average of $3.22.
Galect...